Tirzepatide
Support Weight Loss Medication
A prescription medication option acting on both GIP and GLP-1 pathways. Eligible patients may discuss tirzepatide with the medical provider as part of an individualized weight-management plan.
Dual
GIP + GLP-1 Agonist
Rx
Prescription Option
Weekly
Injection Option
MD
Medical Evaluation Required
Why Tirzepatide is Different
Unlike other GLP-1 medications, Tirzepatide activates two separate hormone receptor pathways: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 simultaneously. This dual activity influences appetite regulation, food intake and metabolic processes, and is reviewed with your medical provider to determine whether it fits your individualized plan.
Dual Mechanism of Action
- GIP Activation: Enhances insulin secretion, reduces glucagon, supports fat metabolism
- GLP-1 Activation: Slows gastric emptying, reduces appetite, promotes satiety
- Combined Activity: Both pathways acting together influence appetite and metabolic regulation
- Metabolic Support: Studied for effects on metabolic health alongside weight management
"I lost 47 pounds in 6 months with Tirzepatide and Coach Kenya's program. The combination of medical support and behavioral coaching is unlike anything else."
— Program Client
What's Included at I.R.I.S.E.
- A prescription medication option acting on both GIP and GLP-1 pathways
- Dual mechanism: targets both GIP and GLP-1 receptors simultaneously
- May be discussed with the medical provider as part of an individualized weight-management plan
- Weekly injection: convenient, once-per-week dosing
- Physician supervised through Dr. Crystal Broussard, MD (licensed in all 50 states)
- Fully integrated with I.R.I.S.E. behavioral and mindset coaching